Central Endoscopy Reading in Inflammatory Bowel Diseases

Central Endoscopy Reading in Inflammatory Bowel Diseases

Endoscopic assessment of the presence and severity of endoscopic lesions has become an essential part of clinical trials in ulcerative colitis and Crohn's disease, for both patient eligibility and outcome measures. Variability in lesion interpretation between and within observers and the potent...

Bibliográfalaš dieđut
Váldodahkkit:	Panés, J, Feagan, BG, Hussain, F, Levesque, BG, Travis, SP
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	Oxford University Press 2016

Geahča maid

Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials.
Dahkki: Gottlieb, K, et al.
Almmustuhtton: (2015)

The future of inflammatory bowel disease management: combining progress in trial design with advances in targeted therapy.
Dahkki: Travis, S, et al.
Almmustuhtton: (2012)

Artificial intelligence in inflammatory bowel disease endoscopy: implications for clinical trials
Dahkki: Ahmad, HA, et al.
Almmustuhtton: (2023)

Respiratory tract infections in patients with inflammatory bowel disease: safety analyses from vedolizumab clinical trials
Dahkki: Feagan, BG, et al.
Almmustuhtton: (2018)

Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
Dahkki: Bourreille, A, et al.
Almmustuhtton: (2009)

Controversies in inflammatory bowel disease: exploring clinical dilemmas using Cochrane Reviews
Dahkki: East, JE, et al.
Almmustuhtton: (2019)

Salicylates for inflammatory bowel disease.
Dahkki: Travis, S, et al.
Almmustuhtton: (1994)

The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis
Dahkki: Travis, S, et al.
Almmustuhtton: (2013)

Improving the quality of care for inflammatory bowel disease
Dahkki: Ye, B, et al.
Almmustuhtton: (2018)

Conventional medical management of inflammatory bowel disease.
Dahkki: Burger, D, et al.
Almmustuhtton: (2011)

Conventional drug therapy for inflammatory bowel disease.
Dahkki: Bryant, R, et al.
Almmustuhtton: (2015)

Guidelines for the management of inflammatory bowel disease in adults.
Dahkki: Carter, M, et al.
Almmustuhtton: (2004)

The genetics of inflammatory bowel disease.
Dahkki: Satsangi, J, et al.
Almmustuhtton: (1997)

Incidence of pneumonia and other respiratory tract infections with vedolizumab treatment for inflammatory bowel disease: clinical trial experience
Dahkki: Feagan, B, et al.
Almmustuhtton: (2017)

Genetics of inflammatory bowel disease.
Dahkki: Satsangi, J, et al.
Almmustuhtton: (1998)

Genetics of inflammatory bowel disease.
Dahkki: Satsangi, J, et al.
Almmustuhtton: (1994)

What is the optimal treatment for anemia in inflammatory bowel disease?
Dahkki: Kent, A, et al.
Almmustuhtton: (2012)

Letter: inflammatory bowel disease guidelines and conflicts of interest.
Dahkki: Eliakim, R, et al.
Almmustuhtton: (2013)

Mucosal healing in inflammatory bowel diseases: a systematic review.
Dahkki: Neurath, M, et al.
Almmustuhtton: (2012)

What's app? Electronic health technology in inflammatory bowel disease
Dahkki: Walsh, A, et al.
Almmustuhtton: (2018)

Atopy in inflammatory bowel disease.
Dahkki: Mee, A, et al.
Almmustuhtton: (1979)

Immunology of inflammatory bowel disease.
Dahkki: Jewell, D, et al.
Almmustuhtton: (1985)

Immunology of inflammatory bowel disease.
Dahkki: Hodgson, H, et al.
Almmustuhtton: (1987)

Arthritis and inflammatory bowel disease.
Dahkki: Wordsworth, P
Almmustuhtton: (2000)

Cytokines and inflammatory bowel disease.
Dahkki: Radford-Smith, G, et al.
Almmustuhtton: (1996)

The immunology of inflammatory bowel disease.
Dahkki: Lowes, JR, et al.
Almmustuhtton: (1990)

Patient-reported goals in inflammatory bowel disease: what’s the problem?
Dahkki: Wong, D, et al.
Almmustuhtton: (2021)

The efficacy of methotrexate for maintaining remission in inflammatory bowel disease.
Dahkki: Fraser, A, et al.
Almmustuhtton: (2002)

Regulatory T cells and inflammatory bowel disease.
Dahkki: Groux, H, et al.
Almmustuhtton: (1999)

Polyp-adjacent biopsies no longer required in inflammatory bowel disease
Dahkki: Lahiff, C, et al.
Almmustuhtton: (2018)

Systematic review: the safety of vedolizumab for the treatment of inflammatory bowel disease.
Dahkki: Bye, W, et al.
Almmustuhtton: (2017)

Evolving concepts in phases I and II drug development for Crohn's Disease
Dahkki: Jairath, V, et al.
Almmustuhtton: (2016)

Surveillance of patients with inflammatory bowel disease
Dahkki: Yu, J, et al.
Almmustuhtton: (2016)

Susceptibility loci in inflammatory bowel disease.
Dahkki: Parkes, M, et al.
Almmustuhtton: (1996)

Cytokine production in inflammatory bowel disease.
Dahkki: Satsangi, J, et al.
Almmustuhtton: (1994)

Inflammatory bowel disease and the X chromosome.
Dahkki: Hayward, P, et al.
Almmustuhtton: (1996)

An integrated taxonomy for monogenic inflammatory bowel disease
Dahkki: Bolton, C, et al.
Almmustuhtton: (2021)

Inflammatory bowel disease and colon cancer.
Dahkki: Jawad, N, et al.
Almmustuhtton: (2011)

Proceedings: Complement in inflammatory bowel disease.
Dahkki: Hodgson, H, et al.
Almmustuhtton: (1975)

The pharmacogenetics of methotrexate in inflammatory bowel disease.
Dahkki: Herrlinger, K, et al.
Almmustuhtton: (2005)